### Revenue Performance
- Total Revenue: $1.567 million, down 81.53% YoY and 69.99% QoQ.
- Gross Profit: $1.37 million, a 140.65% YoY increase indicating improved operational efficiency despite reduced revenues.
### Profitability
- Operating Income: -$39.331 million, a slight improvement (14.18% QoQ), yet highlights ongoing pressure on profitability.
- Net Income: -$43.637 million, which reflects a 33.50% YoY reduction in losses.
### Cash Flow and Balance Sheet
- Net Cash Used In Operations: -$44.1 million, showing high cash burn typical of R&D-intensive firms.
- Cash and Cash Equivalents: $217.229 million, with a current ratio of 11.99 highlighting robust liquidity.
### Investment Metrics
- Debt Ratios: Total debt to capitalization ratio stands at 66.3%, indicating a high leverage situation, which investors must monitor closely.